Citigroup’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-194,090
Closed -$1.13M 5166
2022
Q4
$1.13M Buy
194,090
+73,373
+61% +$428K ﹤0.01% 1922
2022
Q3
$809K Buy
+120,717
New +$809K ﹤0.01% 2248
2021
Q4
Sell
-1,669
Closed -$5K 5312
2021
Q3
$5K Sell
1,669
-281
-14% -$842 ﹤0.01% 4836
2021
Q2
$8K Sell
1,950
-622
-24% -$2.55K ﹤0.01% 5072
2021
Q1
$13K Sell
2,572
-3,967
-61% -$20.1K ﹤0.01% 4846
2020
Q4
$83K Buy
6,539
+5,165
+376% +$65.6K ﹤0.01% 3804
2020
Q3
$13K Sell
1,374
-44,936
-97% -$425K ﹤0.01% 4199
2020
Q2
$461K Buy
46,310
+37,886
+450% +$377K ﹤0.01% 2618
2020
Q1
$74K Buy
8,424
+3,289
+64% +$28.9K ﹤0.01% 3509
2019
Q4
$47K Buy
5,135
+2,020
+65% +$18.5K ﹤0.01% 4010
2019
Q3
$18K Sell
3,115
-4,439
-59% -$25.7K ﹤0.01% 4335
2019
Q2
$91K Buy
7,554
+463
+7% +$5.58K ﹤0.01% 3700
2019
Q1
$85K Buy
7,091
+1,739
+32% +$20.8K ﹤0.01% 3692
2018
Q4
$67K Buy
5,352
+136
+3% +$1.7K ﹤0.01% 3734
2018
Q3
$77K Buy
5,216
+1,336
+34% +$19.7K ﹤0.01% 3777
2018
Q2
$65K Buy
3,880
+99
+3% +$1.66K ﹤0.01% 3711
2018
Q1
$87K Sell
3,781
-738
-16% -$17K ﹤0.01% 3457
2017
Q4
$117K Buy
4,519
+696
+18% +$18K ﹤0.01% 3309
2017
Q3
$56K Sell
3,823
-64
-2% -$937 ﹤0.01% 3624
2017
Q2
$54K Buy
3,887
+2,993
+335% +$41.6K ﹤0.01% 3549
2017
Q1
$15K Buy
894
+55
+7% +$923 ﹤0.01% 4178
2016
Q4
$9K Hold
839
﹤0.01% 4559
2016
Q3
$8K Sell
839
-6,089
-88% -$58.1K ﹤0.01% 4527
2016
Q2
$78K Sell
6,928
-8,607
-55% -$96.9K ﹤0.01% 3469
2016
Q1
$212K Buy
15,535
+6,713
+76% +$91.6K ﹤0.01% 3424
2015
Q4
$167K Buy
8,822
+6,728
+321% +$127K ﹤0.01% 3203
2015
Q3
$39K Sell
2,094
-801
-28% -$14.9K ﹤0.01% 3689
2015
Q2
$43K Buy
2,895
+516
+22% +$7.66K ﹤0.01% 3836
2015
Q1
$36K Sell
2,379
-1,579
-40% -$23.9K ﹤0.01% 4064
2014
Q4
$53K Buy
3,958
+3,907
+7,661% +$52.3K ﹤0.01% 4050
2014
Q3
$1K Sell
51
-57,566
-100% -$1.13M ﹤0.01% 5301
2014
Q2
$582K Buy
57,617
+55,213
+2,297% +$558K ﹤0.01% 1905
2014
Q1
$32K Buy
+2,404
New +$32K ﹤0.01% 4247